CY1105745T1 - Χρηση της 11βητα-(4-ακετυλφαινυλ)-17βητα-υδροξυ-17αλφα(1,1,2,2-πενταφθοροαιθυλ)οιστρα-4,9-διεν-3-ονη για την παρασκευη ενος φαρμακου για την θεραπεια του καρκινου του μαστου, των ωοθηκων και του ενδομητριου, του μυελωματος και του μηνιγγιωματος - Google Patents
Χρηση της 11βητα-(4-ακετυλφαινυλ)-17βητα-υδροξυ-17αλφα(1,1,2,2-πενταφθοροαιθυλ)οιστρα-4,9-διεν-3-ονη για την παρασκευη ενος φαρμακου για την θεραπεια του καρκινου του μαστου, των ωοθηκων και του ενδομητριου, του μυελωματος και του μηνιγγιωματοςInfo
- Publication number
- CY1105745T1 CY1105745T1 CY20061101564T CY061101564T CY1105745T1 CY 1105745 T1 CY1105745 T1 CY 1105745T1 CY 20061101564 T CY20061101564 T CY 20061101564T CY 061101564 T CY061101564 T CY 061101564T CY 1105745 T1 CY1105745 T1 CY 1105745T1
- Authority
- CY
- Cyprus
- Prior art keywords
- acetylphenyl
- dien
- pentafluoroethyl
- hydroxy
- treatment
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 210000004696 endometrium Anatomy 0.000 title 1
- 206010027191 meningioma Diseases 0.000 title 1
- 201000000050 myeloid neoplasm Diseases 0.000 title 1
- 230000003623 progesteronic effect Effects 0.000 abstract 4
- 239000003418 antiprogestin Substances 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000018199 S phase Effects 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μεθόδους και χρήσεις για την επαγωγή απόπτωσης σ' ένα κύτταρο, ιδιαίτερα ένα κύτταρο καρκίνου του μαστού, μέσω της χορήγησης αντιπρογεστερόνων, συγκεκριμένα της αντιπρογεστερόνης 11β-(4-ακετυλφαινυλ)-17β-υδροξυ-17α-(1,1,2,2,2-πενταφθοροαιθυλ)-οιστρα-4,9-διεν-3-όνη ή ενός φαρμακευτικώς ανεκτού παραγώγου ή αναλόγου αυτής. Η εφεύρεση περαιτέρω αναφέρεται στη θεραπευτική αγωγή του καρκίνου όπου ένας δείκτης υψηλού κινδύνου είναι μία αυξημένη ποσότητα ογκοκυττάρων στη φάση S του κυτταρικού κύκλου, η δε θεραπευτική αγωγή περιλαμβάνει μία αντιπρογεστερόνη, συγκεκριμένα την αντιπρογεστερόνη 11 β-(4-ακετυλφαινυλ)-17β-υδροξυ-17α-(1,1,2,2,2-πενταφθοροαιθυλ)-οιστρα-4,9-διεν-3-όνη ή ένα φαρμακευτικώς ανεκτό παράγωγο ή ανάλογο αυτής.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24099100P | 2000-10-18 | 2000-10-18 | |
EP00250342 | 2000-10-18 | ||
PCT/EP2001/012006 WO2002032432A1 (en) | 2000-10-18 | 2001-10-17 | Use of antiprogestins for the induction of apoptosis in a cell |
EP01987669A EP1326617B9 (en) | 2000-10-18 | 2001-10-17 | Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105745T1 true CY1105745T1 (el) | 2010-12-22 |
Family
ID=26072952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101564T CY1105745T1 (el) | 2000-10-18 | 2006-11-01 | Χρηση της 11βητα-(4-ακετυλφαινυλ)-17βητα-υδροξυ-17αλφα(1,1,2,2-πενταφθοροαιθυλ)οιστρα-4,9-διεν-3-ονη για την παρασκευη ενος φαρμακου για την θεραπεια του καρκινου του μαστου, των ωοθηκων και του ενδομητριου, του μυελωματος και του μηνιγγιωματος |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1326617B9 (el) |
JP (1) | JP2004511523A (el) |
KR (1) | KR100668024B1 (el) |
CN (1) | CN1209111C (el) |
AT (1) | ATE334683T1 (el) |
AU (2) | AU2361902A (el) |
BG (1) | BG107744A (el) |
BR (1) | BR0114696A (el) |
CA (1) | CA2423020C (el) |
CY (1) | CY1105745T1 (el) |
CZ (1) | CZ299823B6 (el) |
DE (1) | DE60121980T2 (el) |
DK (1) | DK1326617T3 (el) |
EA (1) | EA010593B1 (el) |
EE (1) | EE200300157A (el) |
ES (1) | ES2269492T3 (el) |
HK (1) | HK1062273A1 (el) |
HR (1) | HRP20030388A2 (el) |
HU (1) | HUP0301433A3 (el) |
IL (2) | IL154976A0 (el) |
MX (1) | MXPA03002955A (el) |
NO (1) | NO20031741L (el) |
NZ (1) | NZ538347A (el) |
PL (1) | PL360157A1 (el) |
PT (1) | PT1326617E (el) |
SI (1) | SI1326617T1 (el) |
SK (1) | SK4702003A3 (el) |
UA (1) | UA76729C2 (el) |
WO (1) | WO2002032432A1 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY27301A1 (es) * | 2001-05-25 | 2003-02-28 | Schering Ag | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata |
US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
EP2136796A2 (en) * | 2007-04-23 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
JP2010524996A (ja) * | 2007-04-23 | 2010-07-22 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Brca媒介性疾患における使用のための、プロゲステロン受容体拮抗薬と、ルテインホルモン放出ホルモン作動薬および拮抗薬との組み合わせ |
US20080268041A1 (en) * | 2007-04-23 | 2008-10-30 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases |
GB0718167D0 (en) | 2007-09-18 | 2007-10-31 | Cancer Rec Tech Ltd | Cancer marker and therapeutic target |
JP6092880B2 (ja) * | 2011-10-04 | 2017-03-08 | インヴァイヴィス ファーマスーティカルズ インコーポレーテッドInvivis Pharmaceuticals Inc. | 抗プロゲスチン感受性腫瘍を特定および治療する方法ならびに系 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
-
2001
- 2001-10-17 EA EA200300479A patent/EA010593B1/ru not_active IP Right Cessation
- 2001-10-17 MX MXPA03002955A patent/MXPA03002955A/es active IP Right Grant
- 2001-10-17 JP JP2002535670A patent/JP2004511523A/ja active Pending
- 2001-10-17 BR BR0114696-3A patent/BR0114696A/pt not_active Application Discontinuation
- 2001-10-17 CZ CZ20031073A patent/CZ299823B6/cs not_active IP Right Cessation
- 2001-10-17 AT AT01987669T patent/ATE334683T1/de not_active IP Right Cessation
- 2001-10-17 CA CA002423020A patent/CA2423020C/en not_active Expired - Fee Related
- 2001-10-17 DK DK01987669T patent/DK1326617T3/da active
- 2001-10-17 UA UA2003054311A patent/UA76729C2/uk unknown
- 2001-10-17 CN CNB018175694A patent/CN1209111C/zh not_active Expired - Fee Related
- 2001-10-17 WO PCT/EP2001/012006 patent/WO2002032432A1/en active IP Right Grant
- 2001-10-17 NZ NZ538347A patent/NZ538347A/en unknown
- 2001-10-17 SI SI200130648T patent/SI1326617T1/sl unknown
- 2001-10-17 SK SK470-2003A patent/SK4702003A3/sk not_active Application Discontinuation
- 2001-10-17 IL IL15497601A patent/IL154976A0/xx active IP Right Grant
- 2001-10-17 ES ES01987669T patent/ES2269492T3/es not_active Expired - Lifetime
- 2001-10-17 DE DE60121980T patent/DE60121980T2/de not_active Expired - Fee Related
- 2001-10-17 PT PT01987669T patent/PT1326617E/pt unknown
- 2001-10-17 PL PL01360157A patent/PL360157A1/xx not_active Application Discontinuation
- 2001-10-17 KR KR1020037005360A patent/KR100668024B1/ko not_active IP Right Cessation
- 2001-10-17 EE EEP200300157A patent/EE200300157A/xx unknown
- 2001-10-17 EP EP01987669A patent/EP1326617B9/en not_active Expired - Lifetime
- 2001-10-17 HU HU0301433A patent/HUP0301433A3/hu unknown
- 2001-10-17 AU AU2361902A patent/AU2361902A/xx active Pending
- 2001-10-17 AU AU2002223619A patent/AU2002223619B2/en not_active Ceased
-
2003
- 2003-03-18 IL IL154976A patent/IL154976A/en not_active IP Right Cessation
- 2003-04-15 NO NO20031741A patent/NO20031741L/no not_active Application Discontinuation
- 2003-04-18 BG BG107744A patent/BG107744A/bg unknown
- 2003-05-14 HR HR20030388A patent/HRP20030388A2/hr not_active Application Discontinuation
-
2004
- 2004-07-20 HK HK04105309A patent/HK1062273A1/xx not_active IP Right Cessation
-
2006
- 2006-11-01 CY CY20061101564T patent/CY1105745T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105745T1 (el) | Χρηση της 11βητα-(4-ακετυλφαινυλ)-17βητα-υδροξυ-17αλφα(1,1,2,2-πενταφθοροαιθυλ)οιστρα-4,9-διεν-3-ονη για την παρασκευη ενος φαρμακου για την θεραπεια του καρκινου του μαστου, των ωοθηκων και του ενδομητριου, του μυελωματος και του μηνιγγιωματος | |
AR011480A1 (es) | ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA. | |
IL154975A0 (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
NO986104L (no) | Progesteron-anti-progesteron regimer | |
BR0008437A (pt) | Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos | |
EA200100828A1 (ru) | 16-гидроксиэстратриены в качестве эстрогенов избирательного действия | |
RU2004121162A (ru) | Применение анастрозола для лечения женщин в постклимактерическом периоде, которые страдают ранним раком молочной железы | |
YU29903A (sh) | Upotreba antiprogestina za indukciju apoptoze u ćeliji | |
EA200200943A1 (ru) | Гормональная терапия рака молочной железы | |
CY1111406T1 (el) | Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης | |
JP2004511523A5 (el) | ||
EA200501739A1 (ru) | Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний | |
BRPI0414945A (pt) | regimes contraceptivos trifásicos estendidos | |
DE60202954D1 (de) | Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel | |
EA200300480A1 (ru) | Применение антипрогестинов для профилактики и лечения гормонозависимых заболеваний | |
TW200733955A (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
SI1937274T1 (sl) | Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo | |
BR0010070A (pt) | Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio | |
Weichselbaum et al. | Alteration of cell cycle parameters by 17 beta estradiol (17 be) in a human breast carcinoma line In vitro: implications for combination therapy in vivo | |
Sampascual et al. | Hepatotoxicidad por tibolona | |
TH84327B (th) | การใช้และชุดสำเร็จรูปแอนโดรเจนสเตอรอยด์ (Androgenic Steriod) แบบที่ไม่ใช้รับประทานในสุภาพสตรี |